Examkin

Soru

Zorluk: OrtaImmunizations and Vaccine-Preventable Diseases

A couple visits the pediatric clinic seeking advice regarding their 9-month-old son. They are planning to travel to Southeast Asia for a month-long family visit, departing in 2 weeks. The region they are visiting is currently experiencing a large, ongoing measles outbreak. The infant was born at term, has no significant past medical history, and is up to date on all routine childhood immunizations. His physical examination today is unremarkable. Which of the following is the most appropriate recommendation regarding measles prophylaxis for this patient?

  1. A
    Administer the measles-mumps-rubella (MMR) vaccine today and give the second dose at age 4-6 years
  2. Administer the measles-mumps-rubella (MMR) vaccine today and give two additional doses beginning at age 12 monthsCevap
  3. C
    Administer intramuscular measles immune globulin today and give the first MMR vaccine dose at age 12 months
  4. D
    Defer any measles-specific intervention until age 12 months because live-attenuated vaccines are contraindicated at this age
  5. E
    Administer the measles-mumps-rubella-varicella (MMRV) vaccine today and give the second dose at age 4-6 years

Cevap

The correct answer is to administer the MMR vaccine today and provide two additional doses starting on or after the infant's first birthday.
Infants aged 6 to 11 months who are traveling internationally to areas with endemic measles should receive one dose of the MMR vaccine prior to departure to provide immediate protection. However, because circulating maternal antibodies can neutralize the live vaccine virus and reduce the infant's own immune response, any dose administered before 12 months of age does not count toward the routine childhood series. Therefore, the child must still receive the standard two-dose MMR series beginning on or after their first birthday (typically administered at 12-15 months and 4-6 years).

Adım Adım Çözüm

1
Identify the patient's demographic profile and clinical risk.
A 9-month-old infant is traveling to an area with an active measles outbreak.
Travel to an endemic area alters routine immunization schedules, particularly for highly contagious diseases like measles.
2
Determine the appropriate pre-travel prophylaxis for this age group.
The CDC recommends one dose of the MMR vaccine for infants aged 6 to 11 months traveling internationally.
Infants in this age bracket are vulnerable to measles as maternal antibodies wane, and the vaccine provides safe and effective early protection.
3
Evaluate how this early dose impacts the routine immunization schedule.
The dose given at 9 months does not count toward the routine two-dose series.
Maternal IgG antibodies circulating in the infant's blood before 12 months of age can blunt the immune response to the live-attenuated vaccine, requiring a full two-dose series to be restarted after the first birthday to ensure lifelong immunity.

Anahtar Kavram

Infants aged 6 to 11 months traveling internationally should receive an early dose of the MMR vaccine; however, this dose does not count toward the routine series, and two additional doses are required starting at age 12 months.
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

Immunizations and Vaccine-Preventable Diseases

Bu konudan daha fazla soru